Oct. 16, 2017 — As the FDA considers the most effective way for pharmaceutical companies to present risks in direct-to-consumer (DTC) ads, a recently published paper in Nature Human Behavior underscores the commonly held belief that consumers do not respond well to a barrage of product risk information. According to the paper abstract, these long […]
Read moreOct. 20, 2015 – The FDA’s announcement last week that it was accepting comments on two new studies of direct-to-consumer (DTC) television advertising for prescription drugs adds these studies to the growing pile of research the agency is accumulating to better understand consumers’ comprehension of what is being communicated through these ads. To help industry […]
Read more